Search

everythinglearnresearchcommunity

for

Search:↓

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Male pattern hair loss affects up to 80% of men due to genetics and hormone sensitivity.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

VEGF and its receptor might cause hair loss.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

Topical finasteride might be a good alternative for hair loss treatment with fewer side effects, but more research is needed.

Androgen receptor degrader drugs may be a promising future treatment for hair loss.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

The conclusion suggests a new treatment for infantile hemangiomas and a potential target for hair loss treatment.

Androgenetic alopecia is a common type of hair loss in men and women, caused by a testosterone byproduct affecting hair follicles, with sensitivity determined by genetics.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

Prepubertal girls have higher sex steroid levels than boys, possibly leading to earlier puberty.

Male and female mice have different skin thickness, and hormones affect their skin and hair growth differently.

Heart-specific steroid metabolism is crucial in cardiac hypertrophy.

2-Methoxyestradiol causes cancer cell death by activating specific pathways, but androgens can block this effect.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

Weak endocrine disruptors in mixtures can have significant effects and should be considered in risk assessments.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

Higher free testosterone levels in men are linked to a stronger immune response, not weaker.